|
NDUFB4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.007200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.262200E-01 |
| Normal-vs-Stage2 |
1.940790E-01 |
| Normal-vs-Stage3 |
2.390000E-02 |
| Normal-vs-Stage4 |
1.262430E-02 |
| Stage1-vs-Stage2 |
2.455900E-02 |
| Stage1-vs-Stage3 |
2.743900E-02 |
| Stage1-vs-Stage4 |
8.164500E-03 |
| Stage2-vs-Stage3 |
1.538930E-03 |
| Stage2-vs-Stage4 |
6.964900E-04 |
| Stage3-vs-Stage4 |
6.202000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.486400E-02 |
| Normal-vs-AfricanAmerican |
1.800240E-01 |
| Normal-vs-Asian |
9.516200E-01 |
| Caucasian-vs-AfricanAmerican |
8.445800E-01 |
| Caucasian-vs-Asian |
8.423600E-02 |
| AfricanAmerican-vs-Asian |
1.255770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.024000E-01 |
| Normal-vs-Female |
2.962600E-01 |
| Male-vs-Female |
7.744800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.412000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.611250E-01 |
| Normal-vs-Age(61-80Yrs) |
5.764600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.713400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.058800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.197800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.464400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.641000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.155800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.827600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.214200E-01 |
| Classical-VS-Follicular |
2.4751000027301E-08 |
| Classical-VS-Other |
2.255800E-01 |
| Classical-VS-Normal |
2.926100E-02 |
| Tall-VS-Follicular |
5.05399999628509E-08 |
| Tall-VS-Other |
2.721700E-02 |
| Tall-VS-Normal |
5.215000E-03 |
| Follicular-VS-Other |
3.782600E-01 |
| Follicular-VS-Normal |
1.454270E-02 |
| Other-VS-Normal |
7.832400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.843400E-01 |
| Normal-vs-N1 |
3.663800E-01 |
| N0-vs-N1 |
2.962400E-01 |
|
|
